J M Smucker Co
Change company Symbol lookup
Select an option...
SJM J M Smucker Co
NKORF Nickel One Resources Inc
NFLX Netflix Inc
MXIM Maxim Integrated Products Inc
MS Morgan Stanley
MLCO Melco Resorts & Entertainment Ltd
MBT Mobil'nye Telesistemy PAO
MMT MFS Multi-Market Income Fund
IMGN ImmunoGen Inc
BEN Franklin Resources Inc

Consumer Staples : Food Products | Mid Cap ValueCompany profile

The J. M. Smucker Company is a manufacturer and marketer of branded food and beverage products and pet food and pet snacks in North America. The Company's segments include U.S. Retail Coffee, U.S. Retail Consumer Foods, U.S. Retail Pet Foods, and International and Foodservice. The Company's U.S. retail market segments consist of the sale of branded food products to consumers through retail outlets in North America. In the U.S. retail market segments, the Company's products are sold to food retailers, food wholesalers, drug stores, club stores, mass merchandisers, discount and dollar stores, military commissaries, natural foods stores and distributors, and pet specialty stores. In International and Foodservice, the Company's products are distributed domestically and in foreign countries through retail channels and foodservice distributors and operators, such as restaurants, lodging, schools and universities, healthcare operators.

Closing Price
Day's Change
1.44 (1.21%)
B/A Size
Day's High
Day's Low

10-day average volume:

UPDATE: Cannabis earnings: Pot stocks' downturn may drown Aurora and others in red ink

8:47 am ET February 11, 2019 (MarketWatch)

By Max A. Cherney

Canadian producers like Aurora Cannabis and Canopy Growth could show losses from decline in investments in other companies

With Aurora Cannabis Inc. and Canopy Growth Corp. reporting earnings in the coming days, investors should watch closely for losses due to their investments in other weed companies.

Recreational cannabis legalization began Oct. 17 in Canada (http://www.marketwatch.com/story/cannabis-is-now-legal-in-canada-but-pot-companies-expect-a-rocky-start-2018-10-17), and despite the federal government's public statements (http://www.marketwatch.com/story/canadian-minister-of-pot-cannabis-inventory-sufficient-to-meet-demand-2019-01-30), in the intervening months, the country is grappling with massive supply shortages (http://www.marketwatch.com/story/canadas-pot-party-big-demand-short-supply-and-stamps-with-no-glue-2018-10-20), according multiple people running companies or working in the sector. Provinces have blamed the licensed cannabis producers (https://www.marketwatch.com/story/canadas-struggle-to-supply-legal-weed-) for the lack of available product, yet the weed producers have said that the shortage and weak September-quarter earnings (http://www.marketwatch.com/story/pot-companies-still-working-out-the-supply-kinks-to-meet-strong-canadian-demand-2018-11-17) are a result of licensing backlogs and provincial buyers placing small orders.

The uncertainty surrounding early returns and supply-chain difficulties have weighed on pot stocks, along with doubts about their outsize valuations.

Don't miss: How marijuana companies will report profit despite not selling pot (http://www.marketwatch.com/story/how-marijuana-companies-can-profit-without-selling-pot-2019-02-08)

Since Oct. 17, ETFMG Alternative Harvest ETF (MJ) has dropped 11%, Horizons Marijuana Life Sciences Index ETF has fallen 14%. After a more than 600% gain on its stock since going public, Tilray Inc. dropped about 40%, Canopy Growth (WEED.T) (WEED.T)has fallen 9.8%. Unlike many of its rivals, Cronos Group Inc. (CRON.T)(CRON.T) has performed well, nearly doubling after it announced that Altria Group Inc. (MO) had taken a $1.8 billion stake in the company.

The downturn could be a problem for Aurora (ACB.T) , (ACB.T) especially, which has said it expects sales of C$50 to C$55 million (http://www.marketwatch.com/press-release/aurora-cannabis-provides-guidance-for-the-second-quarter-of-fiscal-2019-anticipating-net-revenues-of-50m-to-55m-2019-01-08) ($37.6 million to $41.4 million) and reports Monday after the opening bell. While Aurora's portfolio of pot stocks generated large profit (http://www.marketwatch.com/story/aurora-stock-falls-as-earnings-show-cannabis-companys-investments-are-still-the-big-earners-2018-11-12) in September-quarter results, it could report massive losses this time around because of the sector's descent and its specific holdings.

For more: Cronos CEO says $1.8 billion from Big Tobacco is just a beginning for cannabis industry (http://www.marketwatch.com/story/cronos-ceo-says-altria-investment-is-just-the-beginning-2018-12-07)

Cronos aside, the pot stock drop is going to be a especially serious for Aurora, because one of the company's largest investments is in Green Organic Dutchman Holdings Ltd. (TGOD.T) , which gave up its gains from earlier in the year while losing roughly 40% of its value. In a note published late Thursday, Harvest Moon Cannabis Co. CEO Robert Doxtator wrote that he estimates Aurora's portfolio losses (http://harvestmooncannabis.ca/aurora.pdf) at C$425 million for the December quarter.

But the losses will be "on paper" losses and don't directly affect Aurora -- and others' -- ability to produce and sell pot.

Analysts polled by FactSet on average project losses of C$0.6 cents a share on sales of C$51.8 million for Aurora. Note there are only two analysts contributing those estimates, which can make the consensus unreliable. Overall, six analysts cover Aurora with an average target price of C$12.09 a share, which represents a 21% upside from Thursday's closing price. Four have a buy rating, one rates it a hold and one analyst has a sell rating.

Explainomics: Investing in a cannabis company? Make sure to ask these four questions (http://www.marketwatch.com/story/how-marijuana-companies-can-profit-without-selling-pot-2019-02-08)

Canopy Growth, the world's largest pot company by market value, reports Thursday after the close. Canopy's profits may also suffer from the overall sector decline, since it holds a substantial portfolio of public companies, as does its publicly traded venture-capital arm, Canopy Rivers Inc.(RIV.V)

Analysts expect Canopy Growth to report losses of C$0.17 a share on sales of C$84.7 million, according to FactSet. Ten analysts cover the name, nine of which have a buy rating; one rates Canopy a sell. The average price target is C$70.70, which is a 17% upside from Thursday's closing price.

The considerably smaller Supreme Cannabis Co. Inc. (FIRE.V) will report Tuesday before the open. Tilray and Cronos have not announced their earnings dates.

Aphria Inc. (APHA.T)(APHA.T) , which is the target of a hostile takeover bid (http://www.marketwatch.com/story/the-aphria-hostile-takeover-offer-is-littered-with-red-flags-2018-12-28), and Organigram Holdings Inc. (OGI.V) reported results (http://www.marketwatch.com/story/marijuana-stocks-rise-after-organigram-doubles-revenue-forecast-2019-01-28) in January.

-Max A. Cherney; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

February 11, 2019 08:47 ET (13:47 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.